Drugmakers: Canada-EU trade deal won't cost billions

Claims that Canada's proposed trade deal with the EU would add C$2.8 billion a year to that nation's drug costs are based on flawed assumptions and should be ignored, research-based drugmakers have said. Report

Suggested Articles

Belén Garijo, currently CEO of Merck Healthcare, will succeed Stefan Oschmann as the German company's chief exec when his tenure ends in April 2021.

More than 60 researchers and bioethicists called on Pfizer to take time to collect more COVID-19 vaccine safety data, Bloomberg reports. 

Leaked details about an ad campaign to quell coronavirus fears before the election raise "every red flag I could dream of," an ex-HHS official said.